Search research articles
Contact Us
Filters
Showing results (411-420 of 596) with videos related to
Page
of 60
Sort By:
Head & Neck
|
February 19, 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies
Noel M Kramer, Eric M Horwitz, Jonathan Cheng, et al.
Neurosurgery
|
March 19, 2024
Impact of Cerebral Revascularization on Pial Collateral Flow in Patients With Unilateral Moyamoya Disease Using Quantitative Magnetic Resonance Angiography
Brandon A Santhumayor, Timothy G White, Danielle Golub, et al.
Journal of the National Cancer Institute
|
September 10, 2011
Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410
Walter J Curran, Rebecca Paulus, Corey J Langer, et al.
BMC Cancer
|
October 12, 2021
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic
Vivek Nimgaonkar, Charu Aggarwal, Abigail T Berman, et al.
JAMA Oncology
|
July 12, 2019
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial
Joshua M Bauml, Rosemarie Mick, Christine Ciunci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2009
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124
Primo N Lara, Ronald Natale, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2023
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
David H Johnson, Louis Fehrenbacher, William F Novotny, et al.
Cancer
|
May 1, 2012
Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer
James P Stevenson, Corey J Langer, Robert A Somer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
David H Johnson, Louis Fehrenbacher, William F Novotny, et al.
JAMA Oncology
|
February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Salma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Page
of 60
Search research articles
Search
Showing results (411-420 of 596) with videos related to
Sort By:
Page
of 60
Head & Neck
|
February 19, 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies
Noel M Kramer, Eric M Horwitz, Jonathan Cheng, et al.
Neurosurgery
|
March 19, 2024
Impact of Cerebral Revascularization on Pial Collateral Flow in Patients With Unilateral Moyamoya Disease Using Quantitative Magnetic Resonance Angiography
Brandon A Santhumayor, Timothy G White, Danielle Golub, et al.
Journal of the National Cancer Institute
|
September 10, 2011
Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410
Walter J Curran, Rebecca Paulus, Corey J Langer, et al.
BMC Cancer
|
October 12, 2021
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic
Vivek Nimgaonkar, Charu Aggarwal, Abigail T Berman, et al.
JAMA Oncology
|
July 12, 2019
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial
Joshua M Bauml, Rosemarie Mick, Christine Ciunci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2009
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124
Primo N Lara, Ronald Natale, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2023
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
David H Johnson, Louis Fehrenbacher, William F Novotny, et al.
Cancer
|
May 1, 2012
Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer
James P Stevenson, Corey J Langer, Robert A Somer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
David H Johnson, Louis Fehrenbacher, William F Novotny, et al.
JAMA Oncology
|
February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Salma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Page
of 60